Eurofins · 5 months ago
Senior Scientist, Small Molecule Method Development and Validation
Eurofins Scientific is an international life sciences company providing analytical testing services. They are seeking a Senior Scientist to perform method validations, transfers, and verifications for APIs and finished products, applying GMP standards and mentoring junior staff.
BiotechnologyGeneticsHealth CareLife SciencePharmaceutical
Responsibilities
Perform method validations, method transfers, and method verification activities on APIs and finished products
Applies GMP in all areas of responsibility, as appropriate
Performing a large variety of analytical tasks for the validation of analytical methods used in the testing of drug products and raw materials by means of various procedures including HPLC, GC, UV/Vis, and dissolution
Reading, understanding, and interpreting diverse analytical procedures
Conducting analytical investigations
Troubleshoot instrumentation and communicate with vendors when required
Train and mentor junior staff in laboratory procedures
Manage and discuss projects with clients
Qualification
Required
3-5 years of experience with LC chromatographic validation in a GMP environment
Excellent communication (oral and written) and attention to detail
Ability to work independently and as part of a team, self-motivation, adaptability, and a positive attitude
Ability to learn new techniques, perform multiple tasks simultaneously, keep accurate records, follow instructions, and comply with company policies
Higher education degree in analytical chemistry or other related degree concentration
BS and 4+ years of experience, MS and 2+ years of experience, or PhD and 1+ years of experience
Authorization to work in the U.S. without restriction or sponsorship
Benefits
Excellent full time benefits including comprehensive medical coverage, dental, and vision options
Life and disability insurance
401(k) with company match
Paid vacation and holidays
Company
Eurofins
Eurofins provides testing and support services to the pharmaceutical, food, environmental, and consumer products industries.
Funding
Current Stage
Public CompanyTotal Funding
$1.05B2025-06-26Post Ipo Debt· $586.37M
2025-03-27Post Ipo Debt· $431.4M
2021-10-22Grant· $30M
Recent News
2025-12-16
Business Wire
2025-12-08
Company data provided by crunchbase